Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Brainstorm Cell Therapuetics Inc (NASDAQ:BCLI)

3.92
Delayed Data
As of 4:00pm ET
 -0.10 / -2.49%
Today’s Change
2.10
Today|||52-Week Range
5.18
+54.33%
Year-to-Date
No recent news for Brainstorm Cell Therapuetics Inc.

Today’s Trading

Previous close4.02
Today’s open3.94
Day’s range3.90 - 3.98
Volume121,824
Average volume (3 months)61,823
Market cap$75.7M
Dividend yield--
Data as of 4:00pm ET, 12/11/2017

Growth & Valuation

Earnings growth (last year)+41.30%
Earnings growth (this year)-114.81%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book7.59

Competitors

 Today’s
change
Today’s
% change
IMMPImmutep Ltd-0.07-3.97%
AEZSAEterna Zentaris Inc-0.03-1.35%
PRTOProteon Therapeutics...-0.05-2.63%
FSIFlexible Solutions I...-0.05-2.96%
Data as of 3:59pm ET, 12/11/2017

Financials

Next reporting dateMarch 29, 2018
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$0.00
Annual profit (last year)-$5.0M
Net profit margin--

Profile

Sector
Electronic Technology
Industry
Computer Peripherals
President &
Chief Executive Officer
Chaim Lebovits
Chief Operating &
Medical Officer
Ralph Z. Kern
Corporate headquarters
Hackensack, New Jersey

Forecasts